ACCOUNTS - Final Accounts preparation



	Kyra Medical Ltd












	Unaudited
	Financial statements

	For the period ended 31 December 2025

	Registered number: 15836074


Kyra Medical Ltd - Registered number:15836074

Statement of financial position

As at 31 December 2025

	2025	2025
Note	£	£

Fixed assets
Tangible assets	4		30,566
			30,566
Current assets
Stocks		30,481
Debtors	5	133,240
Cash at bank and in hand		7,911
		171,632
Creditors: amounts falling due within one year	6	(89,440)
Net current liabilities			82,192
Total assets less current liabilities			112,758
Creditors: amounts falling due after more than one year			(304,168)

Net liabilities			(191,410)

Capital and reserves
Share capital			1,000
Profit and loss account			(192,410)
			(191,410)

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Page 1


Kyra Medical Ltd - Registered number:15836074

Statement of financial position (continued)

As at 31 December 2025

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

C Green

Director

Date: 7 July 2026

The notes on pages 3 to 7 form part of these financial statements.

Page 2


Kyra Medical Ltd

Notes to the financial statements

For the period ended 31 December 2025

1.	General information

The company is a private company limited by shares and is incorporated in England and Wales. Its registered office is One, Glass Wharf, Bristol, BS2 0ZX. Its registration number is 15836074.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' ('FRS 102') and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the company's accounting policies.

The following principal accounting policies have been applied:

2.2

Going concern

The directors have received confirmation from Kyra Medical Inc, the parent company, that it will provide the financial support to the company for a period of at least twelve months from the date of approval of these financial statements. The directors have no reason to believe that this support will not be fourthcoming. Accordingly, the financial statements have been prepared on a going concern basis.

2.3

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Page 3


Kyra Medical Ltd

Notes to the financial statements

For the period ended 31 December 2025

2.Accounting policies (continued)

2.4

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Sale of goods

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:

∙the company has transferred the significant risks and rewards of ownership to the buyer;

∙the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;

∙the amount of turnover can be measured reliably;

∙it is probable that the company will receive the consideration due under the transaction; and

∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of turnover can be measured reliably;

∙it is probable that the company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

2.6

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount.

2.7

Borrowing costs

All borrowing costs are recognised in profit or loss in the period in which they are incurred.

2.8

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the company in independently administered funds.

Page 4


Kyra Medical Ltd

Notes to the financial statements

For the period ended 31 December 2025

2.Accounting policies (continued)

2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery	-	20%
Fixtures and fittings	-	20%
Office equipment	-	25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

2.10

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

2.11

Debtors

Short-term debtors are measured at transaction price, less any impairment.

2.12

Cash

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

2.13

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

2.14

Financial instruments

The company only enters into financial instrument transactions that result in the recognititon of financial assets and liabilities like trade and other debtors and creditors, and loans to and from related parties.

Page 5


Kyra Medical Ltd

Notes to the financial statements

For the period ended 31 December 2025

Employees

The average monthly number of employees, including directors, during the period was 6.

4.	Tangible fixed assets

	Plant and machinery	Fixtures and fittings	Office equipment	Total
	£	£	£	£
Cost or valuation
Additions	24,774	8,975	1,900	35,649
At 31 December 2025	24,774	8,975	1,900	35,649
Depreciation
Charge for the period	2,940	1,950	193	5,083
At 31 December 2025	2,940	1,950	193	5,083
Net book value
At 31 December 2025	21,834	7,025	1,707	30,566

Debtors

					2025
					£


	Trade debtors	129,322
	Prepayments	3,918
		133,240

6.	Creditors: Amounts falling due within one year
		2025
		£

	Trade creditors	47,163
	Other taxation and social security	15,128
	Other creditors	3,800
	Accruals and deferred income	23,349
		89,440

Page 6


Kyra Medical Ltd

Notes to the financial statements

For the period ended 31 December 2025

7.	Creditors: Amounts falling due after more than one year
		2025
		£

	Amounts owed to group undertakings	304,168
		304,168

8.	Loans

		2025
		£




	Amounts falling due after more than 5 years
	Amounts owed to group undertakings	304,168
		304,168
		304,168

9.	Pension commitments

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £16,273. Contributions totalling to £2,801 were payable to the fund at 31 December 2025.

10.	Controlling party

The smallest group undertaking for which financial statements are prepared, which include the company, is Kyra Medical Inc. Its registered office is 102 Otis St, Northborough, MA 01532, United States.

Page 7